TargetMol

Bcl-xL antagonist 2

Product Code:
 
TAR-T38622
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T38622-200mg200mgEnquire
Quantity:
TAR-T38622-1mg1mg£87.00
Quantity:
TAR-T38622-5mg5mg£166.00
Quantity:
TAR-T38622-1mL1 mL * 10 mM (in DMSO)£184.00
Quantity:
TAR-T38622-10mg10mg£240.00
Quantity:
TAR-T38622-25mg25mg£408.00
Quantity:
TAR-T38622-50mg50mg£557.00
Quantity:
TAR-T38622-100mg100mg£707.00
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges to UK mainland customers, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Austria.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Bcl-xL antagonist 2 is an effective and selective antagonist of Bcl-xL with an IC50 of 91 nM and a Ki of 65 nM. Bcl-xL antagonist 2 induces apoptosis in cancer cells and can be used in studies about chronic lymphocytic leukemia and non-Hodgkin?s lymphoma.
CAS:
1235032-75-3
Formula:
C21H16N4O3S2
Molecular Weight:
436.51
Pathway:
Apoptosis
Purity:
0.9813
SMILES:
O=C(O)C=1N=C(SC1)N2CC=3C(=CC=CC3CC2)C(=O)NC4=NC=5C=CC=CC5S4
Target:
BCL

Documents

References

Koehler MF, et al. Structure-Guided Rescaffolding of Selective Antagonists of BCL-XL. ACS Med Chem Lett. 2014;5(6):662-667. Wang L, et al. Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-XL Inhibitor. ACS Med Chem Lett. 2020;11(10):1829-1836.